Comparison of Two Financial Incentives to Encourage the Use of Adalimumab Biosimilars: Results of a French Experiment Close to Clinicians
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Comparison of Two Financial Incentives to Encourage the Use of Adalimumab Biosimilars: Results of a French Experiment Close to Clinicians ; day:2 ; month:7 ; year:2024 ; pages:1-13
PharmacoEconomics - open ; (2.7.2024), 1-13
- Urheber
-
Tano, Marion
Paubel, Pascal
Ribault, Matthieu
Degrassat-Théas, Albane
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-024-00505-7
- URN
-
urn:nbn:de:101:1-2409202141498.345465125373
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tano, Marion
- Paubel, Pascal
- Ribault, Matthieu
- Degrassat-Théas, Albane
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
Biosimilars – Biosimilars: ja, aber
Biosimilars
Understanding the market dynamics of biosimilars
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Biosimilars : Handbuch
Efficacy of adalimumab in sarcoidosis
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Future of anti-VEGF: biosimilars and biobetters
Biosimilars : ein Handbuch
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
Biosimilars – Biosimilars: ja, aber
Biosimilars
Understanding the market dynamics of biosimilars
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Biosimilars : Handbuch
Efficacy of adalimumab in sarcoidosis
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Future of anti-VEGF: biosimilars and biobetters
Biosimilars : ein Handbuch
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
Biosimilars – Biosimilars: ja, aber
Biosimilars
Understanding the market dynamics of biosimilars
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Biosimilars : Handbuch
Efficacy of adalimumab in sarcoidosis
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Future of anti-VEGF: biosimilars and biobetters